← Leaderboards
Nathanyal J Truax
Baylor University
$144,827
Attributed
$144,827
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.6K · FY2019–22$50K$37.5K$25K$12.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$144,827 · 1
By mechanism
F31$144,827 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor University
Same institution · by research overlap
- Daniel Romo$12,118,557
- Liela Romero$1,013,200
- Kyle M. Lambert$111,804
- Bob R Kane$872,519
Others in their field
Other Emerging Leaders on “Alder Plant”
- Wei Wang · University Of New Mexico$941,986
- Callum Bell · National Center For Genome Resources$476,246
- Barrington Herman · National Center For Genome Resources$476,246
- Arundhati Nag · Clark University (Worcester, Ma)$450,862
- Amir Kamal Miri Ramsheh · Rowan University$271,239
- James J La Clair · Texas State University$187,000
Research focus
Alder PlantAlamarblueAnti-CancerAnticancer ActivityAnalogAnti-Inflammatory AgentsAntineoplastic AgentsBioactive Natural ProductsBiologicalCancer Cell LineCell PhysiologyCellsCellular TargetingChloridesCollaborationsCollectionComplexCounterscreenCyclohexanonesCytotoxicityDrug DevelopmentDrug DiscoveryFermentationGlean
Grant awards (4)
Pharmacophore Directed Retrosynthesis Toward the Anti-Inflammatory Agent Rameswaralide and Anti-Cancer Agent Ineleganolide$43,604
F31 · FY2022 · CA · contact PI
Pharmacophore Directed Retrosynthesis Toward the Anti-Inflammatory Agent Rameswaralide and Anti-Cancer Agent Ineleganolide$16,983
F31 · FY2021 · CA · contact PI
Pharmacophore Directed Retrosynthesis Toward the Anti-Inflammatory Agent Rameswaralide and Anti-Cancer Agent Ineleganolide$42,372
F31 · FY2020 · CA · contact PI
Pharmacophore Directed Retrosynthesis Toward the Anti-Inflammatory Agent Rameswaralide and Anti-Cancer Agent Ineleganolide$41,868
F31 · FY2019 · CA · contact PI